Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis

Archives of Ophthalmology

Volumn 115, Issue 6, 1997, Pages 801-802

  Friedberg, Dorothy N ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE HYPOTONIA; PRIORITY JOURNAL; RETINITIS; VISUAL IMPAIRMENT;

EID: 0030910796     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150803021     Document Type: Article

References (4)

1. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Patenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial Ann Intern Med. 1997;126:264-274.
2. Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, de Clercq E, Freeman WR. Intravitreal cidofovir treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1995;102:102:533-543.
3. Kirsch LS, Arevalo JF, de Clercq E, et al. Phase 1/11 study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Am J Ophthalmol. 1995;119:466-476.
4. ̇ T-lymphocyte counts in patients with human immunodeficiency virus with and without cytomegalovirus reunitis. Am J Ophthalmol. 1996;122:91-96